W Conrad Liles Selected Research

W Conrad Liles Research Topics

Disease

46	Infections 01/2024 - 05/2002
36	Inflammation (Inflammations) 01/2024 - 06/2003
34	Malaria 12/2020 - 05/2008
28	Sepsis (Septicemia) 01/2024 - 01/2006
17	Critical Illness (Critically Ill) 12/2023 - 08/2006
12	Acute Lung Injury 01/2024 - 09/2005
12	Cerebral Malaria 01/2017 - 11/2006
9	Lung Injury 01/2024 - 09/2005
8	COVID-19 12/2023 - 01/2021
7	Pneumonia (Pneumonitis) 01/2022 - 03/2004
6	Acute Kidney Injury (Acute Renal Failure) 07/2023 - 10/2016
5	Respiratory Insufficiency (Respiratory Failure) 07/2023 - 08/2006
5	Thrombosis (Thrombus) 01/2023 - 02/2016
5	Fever (Fevers) 12/2022 - 09/2009
5	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2020 - 06/2004
5	Septic Shock (Toxic Shock Syndrome) 01/2019 - 04/2011
5	Communicable Diseases (Infectious Diseases) 08/2013 - 05/2002
4	Cystic Fibrosis (Mucoviscidosis) 01/2024 - 01/2020
4	Wounds and Injuries (Trauma) 07/2023 - 01/2019
4	HIV Infections (HIV Infection) 01/2023 - 08/2013
4	Human Influenza (Influenza) 01/2021 - 07/2011
4	Falciparum Malaria (Plasmodium falciparum Malaria) 03/2013 - 09/2009
3	Fibrosis (Cirrhosis) 01/2024 - 01/2018
3	Necrosis 01/2022 - 01/2009
3	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2020 - 01/2017
3	Neoplasms (Cancer) 01/2019 - 11/2017
2	Bacterial Infections (Bacterial Infection) 01/2024 - 01/2023
2	Weight Loss (Weight Reduction) 01/2024 - 01/2023
2	Shock 12/2022 - 04/2011
2	Thrombocytopenia (Thrombopenia) 11/2017 - 02/2012
2	Cytokine Release Syndrome 11/2017 - 07/2011
2	Anemia 11/2016 - 10/2016
2	Reperfusion Injury 03/2016 - 01/2013
2	Multiple Organ Failure (MODS) 02/2016 - 01/2006
2	Ventilator-Associated Pneumonia 01/2016 - 08/2006
2	Bacteremia 01/2016 - 01/2013

Drug/Important Bio-Agent (IBA)

45	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2009
19	CytokinesIBA 01/2023 - 05/2002
16	Angiopoietin-2IBA 01/2023 - 02/2011
15	Angiopoietin-1IBA 11/2021 - 09/2007
12	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2006
9	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 01/2011
8	Toll-Like Receptors (Toll-Like Receptor)IBA 04/2017 - 07/2005
7	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 11/2021 - 01/2011
7	ArtesunateIBA 11/2016 - 01/2011
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2013
5	LipopolysaccharidesIBA 01/2022 - 03/2004
5	InterferonsIBA 04/2020 - 05/2002
5	Antimalarials (Antimalarial Agents)IBA 01/2016 - 09/2009
5	AngiopoietinsIBA 01/2016 - 01/2009
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 07/2023 - 01/2017
4	InterleukinsIBA 12/2022 - 01/2014
4	von Willebrand FactorIBA 01/2022 - 08/2013
4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 11/2021 - 07/2013
4	Lactic Acid (Lactate)FDA LinkGeneric 01/2020 - 04/2014
4	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2019 - 07/2011
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2014 - 01/2003
3	Therapeutic UsesIBA 01/2022 - 05/2002
3	ChemokinesIBA 01/2020 - 05/2012
3	Chimeric Antigen ReceptorsIBA 01/2020 - 11/2017
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2017 - 09/2009
3	EnzymesIBA 02/2017 - 03/2013
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 05/2002
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2013 - 10/2009
3	Antiviral Agents (Antivirals)IBA 01/2013 - 07/2011
3	Fas Ligand Protein (Fas Ligand)IBA 06/2011 - 03/2004
3	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 12/2008 - 05/2002
3	Caspase 3 (Caspase-3)IBA 09/2005 - 07/2003
3	plerixafor FDA Link 04/2005 - 10/2003
2	mirdametinibIBA 01/2024 - 01/2023
2	Leukocyte L1 Antigen Complex (Calgranulin)IBA 12/2023 - 12/2018
2	C-Reactive ProteinIBA 01/2023 - 11/2021
2	AntibodiesIBA 09/2022 - 12/2020
2	Triggering Receptor Expressed on Myeloid Cells-1IBA 01/2022 - 09/2016
2	EndotoxinsIBA 01/2022 - 11/2012
2	Serum Amyloid A Protein (Serum Amyloid A)IBA 11/2021 - 01/2021
2	P-SelectinIBA 11/2021 - 08/2013
2	Apolipoprotein A-I (Apolipoprotein A1)IBA 11/2021 - 01/2019
2	LeptinIBA 10/2021 - 01/2011
2	salicylhydroxamic acid (SHAM)IBA 01/2021 - 01/2019
2	ivacaftorIBA 04/2020 - 01/2020
2	AntigensIBA 01/2019 - 02/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019 - 08/2013
2	HMGB1 Protein (HMG1)IBA 01/2019 - 03/2013
2	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 02/2017
2	Interleukin-10 (Interleukin 10)IBA 01/2019 - 06/2011
2	Interleukin-8 (Interleukin 8)IBA 12/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 12/2018 - 07/2005
2	Transcription Factors (Transcription Factor)IBA 02/2017 - 03/2006
2	ImmunosorbentsIBA 01/2017 - 03/2013
2	Oxidants (Oxidizing Agents)IBA 11/2016 - 01/2003
2	Endothelial Growth FactorsIBA 01/2016 - 05/2011

Therapy/Procedure

40	Therapeutics 01/2024 - 11/2002
7	Artificial Respiration (Mechanical Ventilation) 01/2021 - 09/2005
6	Ligation 01/2021 - 06/2003
5	Punctures 01/2021 - 10/2010
3	Drug Therapy (Chemotherapy) 12/2017 - 12/2011
2	Precision Medicine 07/2023 - 01/2023
2	Critical Care (Surgical Intensive Care) 01/2022 - 09/2009
2	Transplantation 01/2021 - 11/2002